These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 23560587

  • 1. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
    Willenbacher W, Willenbacher E, Brunner A, Manzl C.
    Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
    [No Abstract] [Full Text] [Related]

  • 2. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR.
    N Engl J Med; 2012 Aug 30; 367(9):826-33. PubMed ID: 22931316
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
    Correa JG, Cibeira MT, Tovar N, Isola I, Pedrosa F, Díaz T, Lozano E, Magnano L, Rosiñol L, Bladé J, Fernández de Larrea C.
    Br J Haematol; 2017 Dec 30; 179(5):849-851. PubMed ID: 27605200
    [No Abstract] [Full Text] [Related]

  • 4. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX, Meng Q, Cai H, He TH, Zhang CL, Su W, Sun J, Li Y, Xu W, Zhou DB, Li J.
    Ann Hematol; 2017 Jun 30; 96(6):971-976. PubMed ID: 28280994
    [Abstract] [Full Text] [Related]

  • 5. MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders.
    Ondrejka SL, Lin JJ, Warden DW, Durkin L, Cook JR, Hsi ED.
    Am J Clin Pathol; 2013 Sep 30; 140(3):387-94. PubMed ID: 23955458
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
    Elba S, Castellino A, Soriasio R, Castellino C, Bonferroni M, Mattei D, Strola G, Drandi D, Mordini N, Foglietta M, Rapezzi D, Celeghini I, Grasso M, Giordano F, Fraternali Orcioni G, Massaia M.
    J Med Case Rep; 2020 Jun 22; 14(1):75. PubMed ID: 32564775
    [Abstract] [Full Text] [Related]

  • 7. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
    Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, Morra E, Trojani A, Greco A, Arcaini L, Varettoni M, Brown JR, Tai YT, Anderson KC, Munshi NC, Patterson CJ, Manning RJ, Tripsas CK, Lindeman NI, Treon SP.
    Blood; 2013 Mar 14; 121(11):2051-8. PubMed ID: 23321251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.
    Drandi D, Genuardi E, Dogliotti I, Ferrante M, Jiménez C, Guerrini F, Schirico ML, Mantoan B, Muccio V, Lia G, Zaccaria GM, Omedè P, Passera R, Orsucci L, Benevolo G, Cavallo F, Galimberti S, Sanz RG, Boccadoro M, Ladetto M, Ferrero S.
    Haematologica; 2018 Jun 14; 103(6):1029-1037. PubMed ID: 29567768
    [Abstract] [Full Text] [Related]

  • 10. Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.
    Xu L, Hunter ZR, Tsakmaklis N, Cao Y, Yang G, Chen J, Liu X, Kanan S, Castillo JJ, Tai YT, Zehnder JL, Brown JR, Carrasco RD, Advani R, Sabile JM, Argyropoulos K, Lia Palomba M, Morra E, Trojani A, Greco A, Tedeschi A, Varettoni M, Arcaini L, Munshi NM, Anderson KC, Treon SP.
    Br J Haematol; 2016 Mar 14; 172(5):735-44. PubMed ID: 26659815
    [Abstract] [Full Text] [Related]

  • 11. An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation.
    Minzenmayer AN, Miranda RN, Powell PR, Parekh PK.
    J Cutan Pathol; 2020 Sep 14; 47(9):850-853. PubMed ID: 32335928
    [Abstract] [Full Text] [Related]

  • 12. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.
    Jiménez C, Sebastián E, Chillón MC, Giraldo P, Mariano Hernández J, Escalante F, González-López TJ, Aguilera C, de Coca AG, Murillo I, Alcoceba M, Balanzategui A, Sarasquete ME, Corral R, Marín LA, Paiva B, Ocio EM, Gutiérrez NC, González M, San Miguel JF, García-Sanz R.
    Leukemia; 2013 Aug 14; 27(8):1722-8. PubMed ID: 23446312
    [Abstract] [Full Text] [Related]

  • 13. Pyrosequencing as a fast and reliable method in detecting the MYD88 p.L265P mutation in decalcified formalin-fixed and paraffin-embedded tissues.
    Gebauer N, Bernard V, Röhner C, Krokowski M, Merz H, Feller AC, Thorns C.
    Ann Lab Med; 2014 Mar 14; 34(2):170-3. PubMed ID: 24624358
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.
    Treon SP, Gustine J, Xu L, Manning RJ, Tsakmaklis N, Demos M, Meid K, Guerrera ML, Munshi M, Chan G, Chen J, Kofides A, Patterson CJ, Yang G, Liu X, Severns P, Dubeau T, Hunter ZR, Castillo JJ.
    Br J Haematol; 2018 Feb 14; 180(3):374-380. PubMed ID: 29181840
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.